1. Home
  2. ATAI vs SLQT Comparison

ATAI vs SLQT Comparison

Compare ATAI & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • SLQT
  • Stock Information
  • Founded
  • ATAI 2018
  • SLQT 1999
  • Country
  • ATAI Germany
  • SLQT United States
  • Employees
  • ATAI N/A
  • SLQT N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • SLQT Specialty Insurers
  • Sector
  • ATAI Health Care
  • SLQT Finance
  • Exchange
  • ATAI Nasdaq
  • SLQT Nasdaq
  • Market Cap
  • ATAI 444.7M
  • SLQT 386.9M
  • IPO Year
  • ATAI 2021
  • SLQT 2020
  • Fundamental
  • Price
  • ATAI $3.85
  • SLQT $1.81
  • Analyst Decision
  • ATAI Strong Buy
  • SLQT Hold
  • Analyst Count
  • ATAI 3
  • SLQT 2
  • Target Price
  • ATAI $13.33
  • SLQT $3.38
  • AVG Volume (30 Days)
  • ATAI 6.6M
  • SLQT 1.1M
  • Earning Date
  • ATAI 08-12-2025
  • SLQT 09-12-2025
  • Dividend Yield
  • ATAI N/A
  • SLQT N/A
  • EPS Growth
  • ATAI N/A
  • SLQT N/A
  • EPS
  • ATAI N/A
  • SLQT N/A
  • Revenue
  • ATAI $1,863,000.00
  • SLQT $1,488,701,000.00
  • Revenue This Year
  • ATAI $423.05
  • SLQT $17.72
  • Revenue Next Year
  • ATAI N/A
  • SLQT $12.79
  • P/E Ratio
  • ATAI N/A
  • SLQT N/A
  • Revenue Growth
  • ATAI 572.56
  • SLQT 20.41
  • 52 Week Low
  • ATAI $1.03
  • SLQT $1.62
  • 52 Week High
  • ATAI $4.00
  • SLQT $6.86
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 69.83
  • SLQT 27.82
  • Support Level
  • ATAI $3.06
  • SLQT $2.07
  • Resistance Level
  • ATAI $3.70
  • SLQT $2.25
  • Average True Range (ATR)
  • ATAI 0.28
  • SLQT 0.10
  • MACD
  • ATAI 0.03
  • SLQT -0.04
  • Stochastic Oscillator
  • ATAI 89.08
  • SLQT 4.80

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

Share on Social Networks: